Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
Status:
Withdrawn
Trial end date:
2021-08-19
Target enrollment:
Participant gender:
Summary
This pilot clinical trial studies how well ferumoxytol-enhanced magnetic resonance imaging
(MRI) works in imaging lymph nodes in patients with stage IIB-IIIC esophageal cancer.
Ferumoxytol is a form of very small iron particles that are taken up by cells in normal lymph
nodes and may work better in imaging patients with esophageal cancer when paired with MRI.
Phase:
Early Phase 1
Details
Lead Sponsor:
OHSU Knight Cancer Institute
Collaborators:
National Cancer Institute (NCI) Oregon Health and Science University